SCHEMBL28986222

SCHEMBL28986222

Nc1ncc2ncn(-c3ccnc(Br)c3)c2n1

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ NT5E P21589 1/20 0.40
▸ HSP90AA1 P07900 1/20 0.38
▸ HSP90AB1 P08238 1/20 0.38
▸ HDAC6 Q9UBN7 2/20 0.37
▸ ROCK1 Q13464 1/20 0.37
▸ MAP3K14 Q99558 8/20 0.36
▸ RPS6KA3 P51812 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ ALOX5AP P20292 1/20 0.35
▸ IRAK4 Q9NWZ3 2/20 0.35
▸ MAPKAPK2 P49137 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30219641 0.81 DHFR (0.49) NT5EHSP90AA1HSP90AB1HDAC6RPS6KA3
SCHEMBL28301793 0.81 DHFR (0.49) NT5EHSP90AA1HSP90AB1HDAC6RPS6KA3
SCHEMBL26270377 0.79 MAPKAPK2 (0.55) ROCK1MAP3K14MAPKAPK2
SCHEMBL30219585 0.79 MAPKAPK2 (0.55) ROCK1MAP3K14MAPKAPK2
SCHEMBL28986241 0.78 RPS6KA3 (0.45) NT5EHSP90AA1HSP90AB1HDAC6RPS6KA3
SCHEMBL30219549 0.78 RPS6KA3 (0.45) NT5EHSP90AA1HSP90AB1HDAC6RPS6KA3
SCHEMBL29139810 0.76 FGFR1 (0.47) ROCK1KDM4EALDH1A1HTTRAB9A
SCHEMBL4978113 0.74 XDH (0.48) HDAC6RPS6KA3KDM4EALDH1A1HTT
SCHEMBL2411704 0.72 MAPKAPK2 (0.67) ROCK1RPS6KA3KDM4EALDH1A1RAB9A
Phenol SCHEMBL28142595 0.70 FGFR1 (0.49) NT5ERPS6KA3HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109810110-B Compound with 2-aminopyrimidine structure, preparation method and application thereof 中国科学院上海药物研究所 2023-01-24 — — CN disclosed
Send feedback